Start This Party: W...
Health Care: Drugs
Akorn Inc. (AKRX: NASDAQ)
$14.83 0.33 | 2.28%
05/20/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:37.18
Price Earnings Comparisons:
| AKRX | Sector Avg. | S&P 500 |
|---|---|---|
| 37.18 | 37.20 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 13.10 | 15.14 | 393.20 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 87.10 | 2.38 | 0.49 |
| Net Income | 0.00 | 0.00 | |
| EPS | -22.00 | -2.32 | 0.00 |
Earnings for AKRX:
| EBITDA | 89.51M |
| REVENUE | 256.16M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.11 | $0.13 | $0.51 | $0.69 |
| Number of Analysts | 2 | 2 | 3 | 3 |
| High Estimate | $0.11 | $0.13 | $0.52 | $0.70 |
| Low Estimate | $0.11 | $0.12 | $0.50 | $0.68 |
| Prior Year | $0.11 | $0.14 | $0.46 | $0.51 |
| Growth Rate (Year over Year) | 0.00% | -10.71% | 10.14% | 36.84% |
Portfolios with AKRX
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- UserGFNN Stockdiagnostics 18
- ContributorStocks Rising On Unusual Vo...
- UserGFNN Stockdiagnostics 16
- UserGFNN Stockdiagnostics 11
- Userpharmacy
- UserGFNN Stockdiagnostics 4
- UserGFNN Stockdiagnostics
- ContributorStocks At New 52-Week Highs...
Latest AKRX Headlines from TheStreet
- AKRX Crosses Below Key Moving Average Level 05.07.13 | 11:05 am
- 5 Stock Insiders are Gobbling Up 12.19.12 | 12:12 pm
- Akorn CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.07.12 | 12:08 pm
- Cramer's 'Mad Money" Recap: Curb Your Enthusiasm 07.11.12 | 07:07 pm
- 7 High-Volume Stocks With Relative Strength 07.09.12 | 02:07 pm
- Akorn Stock Hits New 52-Week High (AKRX) 06.19.12 | 11:06 am
- Akorn Reaches New 52-Week High (AKRX) 06.08.12 | 03:06 pm
- Akorn Inc. (AKRX): Today's Featured Drugs Loser 06.06.12 | 06:06 pm
- Akorn Inc. (AKRX): Today's Featured Drugs Loser 06.06.12 | 05:06 pm
- Akorn Stock Hits New 52-Week High (AKRX) 05.30.12 | 02:05 pm
Press Releases for AKRX
- Akorn Reports 2012 Fourth Quarter And Year-End Financial Results - Business Wire 02.26.13 | 07:02 am
- Akorn Provides Financial Guidance For 2013 - Business Wire 01.17.13 | 02:01 pm
- Akorn Reports Third Quarter 2012 Financial Results - Business Wire 11.06.12 | 06:11 am
- Akorn Announces The Approval And Launch Of Generic Prometrium® - Business Wire 10.24.12 | 06:10 am
- Akorn’s Chairman Adopts 10b5-1 Trading Plan - Business Wire 09.24.12 | 11:09 am
- Akorn Announces New Management Appointments - Business Wire 08.07.12 | 07:08 am
- Akorn Reports Preliminary Second Quarter 2012 Financial Results - Business Wire 08.07.12 | 07:08 am
- Akorn To File Amended Unaudited Financial Statements For The Quarter Ended March 31, 2012 - Business Wire 08.07.12 | 06:08 am
- Akorn Reports Record First Quarter 2012 Financial Results - Business Wire 05.08.12 | 06:05 am
- Akorn Announces The Approval And Launch Of Generic Vancocin® - Business Wire 04.10.12 | 06:04 am
Partner Headlines for AKRX
- 5 Big Buys By Oak Ridge Investments - Seeking Alpha 11.10.12 | 01:11 am
- Weekly CFO Sells Highlight: ASGN, COF, AKRX, MCRS, GILD, ROP, PLL - NASDAQ 09.24.12 | 02:09 pm
- Healthcare Business Review: Savient's Favorable RULING, Forest Gets FDA OKAY - Wall St. Cheat Sheet 07.24.12 | 08:07 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 07.09.12 | 09:07 am
- Las Vegas Sands a BUY and 4 Must-See Expert Insights - Wall St. Cheat Sheet 07.09.12 | 04:07 am
- Zacks Releases Four Powerful ''Buy'' Stocks: BE Aerospace, Yum! Brands, Akorn and H.B. Fuller - Press Releases - Zacks 02.08.12 | 09:02 am
- Akorn, Inc. - Momentum - Zacks 02.08.12 | 01:02 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 01.20.12 | 09:01 am
- End-of-Day Market Summary for December 23, 2011 - Benzinga 12.23.11 | 04:12 pm
- Hearing Akorn Recent Weakness Attributed to FDA Inspection Letter - Benzinga 12.23.11 | 11:12 am
